Evidence map›Paper›PMID 20863880›Full record

ArticleBrain, behavior, and immunity2011

Anti-depressant medication use and C-reactive protein: results from two population-based studies.

Mark Hamer, G D Batty, Michael G Marmot, Archana Singh-Manoux, Mika Kivimäki

Abstract read
In one paragraph

Article in Brain, behavior, and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Modulation of microglial activation by antidepressants.Journal of psychopharmacology (Oxford, England) · 2022
    Review
  14. Review
  15. Review
  16. Does CRP predict outcome in bipolar disorder in regular outpatient care?International journal of bipolar disorders · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mark HamerDepartment of Epidemiology and Public Health, University College London, London, UK. m.hamer@ucl.ac.uk
G D Batty
Michael G Marmot
Archana Singh-Manoux
Mika Kivimäki

Funding

Socio-economic status and heterogeneity in agingR01AG013196 · NIA · UNIVERSITY OF LONDON INST OF NEUROLOGY · PI MARMOT, MICHAEL G, SINGH-MANOUX, ARCHANA · 1996 to 2013
$3.5M
Socioeconomic gradient in CHD in early old ageR01HL036310 · NHLBI · UNIVERSITY OF LONDON · PI KIVIMAKI, MIKA J, MARMOT, MICHAEL G · 1986 to 2012
$3.1M
Health behaviors over the adult lifecourse and cognitive agingR01AG034454 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2009 to 2013
$1.5M
Biotechnology and Biological Sciences Research CouncilBritish Heart Foundation RG 05/006British Heart Foundation RG/07/008/23674British Heart Foundation RG/10/005/28296Chief Scientist OfficeDepartment of HealthMedical Research Council G0100222Medical Research Council G0902037Medical Research Council G19/35Medical Research Council G8802774Medical Research Council MC_U130059821NHLBI NIH HHS R01 HL036310NHLBI NIH HHS R01HL036310NIA NIH HHS R01 AG013196NIA NIH HHS R01AG013196NIA NIH HHS R01 AG034454NIA NIH HHS R01AG034454Wellcome TrustWellcome Trust WBS U.1300.00.006.00012.01
6 · The paper itself

Abstract

The use of anti-depressant medication has been linked to cardiovascular disease (CVD). We examined the association between anti-depressant medication use and a marker of low grade systemic inflammation as a potential pathway linking anti-depressant use and CVD in two population based studies. Data were collected in a representative sample of 8131 community dwelling adults (aged 47.4±15.9 years, 46.7% male) from the Scottish Health Surveys (SHS). The use of anti-depressant medication was coded according to the British National Formulary and blood was drawn for the measurement of C-reactive protein (CRP). In a second study, we attempted to replicate our findings using longitudinal data from the Whitehall II study (n=4584, aged 55.5±5.9 years, mean follow-up 5.5 years). Antidepressants were used in 5.6% of the SHS sample, with selective serotonin reuptake inhibitors (SSRIs) being the most common. There was a higher risk of elevated CRP (>3 mg/L) in users of tricyclic antidepressant (TCA) medication (multivariate adjusted odds ratio (OR)=1.52, 95% CI, 1.07-2.15), but not in SSRI users (multivariate adjusted OR=1.07, 95% CI, 0.81-1.42). A longitudinal association between any antidepressant use and subsequent CRP was confirmed in the Whitehall cohort. In summary, the use of anti-depressants was associated with elevated levels of systemic inflammation independently from the symptoms of mental illness and cardiovascular co-morbidity. This might be a potential mechanism through which antidepressant medication increases CVD risk. Further data are required to explore the effects of dosage and duration of antidepressant treatment.

Indexed as

AdultAntidepressive AgentsAntidepressive Agents, TricyclicBiomarkersCardiovascular DiseasesCohort StudiesC-Reactive ProteinDepressive DisorderDrug UtilizationFemaleHealth SurveysHumansLongitudinal StudiesMaleMiddle AgedPopulationAntidepressive AgentsAntidepressive Agents, TricyclicBiomarkersC-Reactive ProteinSelective Serotonin Reuptake Inhibitors

Identifiers

PMID20863880
PMCPMC3014524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.